Fabio M Iwamoto

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Metastatic Colorectal Cancer

Mesenchymal Stem Cells

Cell Proliferation

Top Venues

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Prabhjot S Mundi, Filemon Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R Rainey, Kristina Guillan, Armaan Siddiquee, Daoqi You, Ronald Realubit, Charles Karan, Michael V Ortiz, Eugene F Douglass, Melissa K Accordino, Suzanne Mistretta, Frances L Brogan, Jeffrey N Bruce, Cristina I Caescu, Richard D Carvajal, Katherine D Crew, Guarionex Decastro, Mark Heaney, Brian S Henick, Dawn L Hershman, June Y Hou, Fabio M Iwamoto, Joseph G Jurcic, Ravi P Kiran, Michael D Kluger, Teri Kreisl, Nicole Lamanna, Andrew B Lassman, Emerson A Lim, Gulam A Manji, Guy M McKhann, James M McKiernan, Alfred I Neugut, Kenneth P Olive, Todd Rosenblat, Gary K Schwartz, Catherine A Shu, Michael B Sisti, Ana I Tergas, Reena M Vattakalam, Mary R Welch, Sven Wenske, Jason D Wright, Peter Canoll, Hanina Hibshoosh, Kevin M Kalinsky, Mahalaxmi Aburi, Peter A Sims, Mariano J Alvarez, Andrew L Kung, Andrea Califano
A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies. Cancer discovery (2023)
Connor J Kinslow, Ali I Rae, Kekoa Taparra, Prashanth Kumar, Markus D Siegelin, Jack Grinband, Brian J A Gill, Guy M McKhann, Michael B Sisti, Jeffrey N Bruce, Peter D Canoll, Fabio M Iwamoto, David P Horowitz, Lisa A Kachnic, Alfred I Neugut, James B Yu, Simon K Cheng, Tony J C Wang
MGMT promoter methylation predicts overall survival after chemotherapy for 1p/19q-codeleted gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Víctor A Arrieta, Andrew X Chen, J Robert Kane, Seong Jae Kang, Cynthia Kassab, Crismita Dmello, Junfei Zhao, Kirsten B Burdett, Pavan S Upadhyayula, Catalina Lee-Chang, Joseph Shilati, Dinesh Jaishankar, Li Chen, Andrew Gould, Daniel Yang Zhang, Jinzhou Yuan, Wenting Zhao, Xiaoyang Ling, Jared K Burks, Brice Laffleur, Christina Amidei, Jeffrey N Bruce, Rimas V Lukas, Jonathan T Yamaguchi, David Cieremans, Gerson Rothschild, Uttiya Basu, Matthew McCord, Daniel J Brat, Hui Zhang, Lee A D Cooper, Bin Zhang, Peter Sims, Timothy F Cloughesy, Robert M Prins, Peter Canoll, Roger Stupp, Amy B Heimberger, Craig M Horbinski, Fabio M Iwamoto, Raúl Rabadán, Adam M Sonabend
ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma. Nature cancer 2 (12) (2021)
Junfei Zhao, Andrew X Chen, Robyn D Gartrell, Andrew M Silverman, Luis Aparicio, Tim Chu, Darius Bordbar, David Shan, Jorge Samanamud, Aayushi Mahajan, Ioan Filip, Rose Orenbuch, Morgan Goetz, Jonathan T Yamaguchi, Michael Cloney, Craig Horbinski, Rimas V Lukas, Jeffrey Raizer, Ali I Rae, Jinzhou Yuan, Peter Canoll, Jeffrey N Bruce, Yvonne M Saenger, Peter Sims, Fabio M Iwamoto, Adam M Sonabend, Raúl Rabadán
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma. Nature medicine 25 (3) (2019)